Stockscreener 앱 받기
214.55
1.88%
3.96
전일 마감가:
$210.59
열려 있는:
$214.7
하루 거래량:
905.90K
Relative Volume:
0.85
시가총액:
$14.88B
수익:
$2.88B
순이익/손실:
$499.60M
주가수익비율:
31.83
EPS:
6.74
순현금흐름:
$321.60M
1주 성능:
+6.27%
1개월 성능:
-4.98%
6개월 성능:
-30.32%
1년 성능:
-41.73%
1일 변동 폭
$209.38
$214.76
1주일 범위
$199.89
$223.09
52주 변동 폭
$187.43
$372.79
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
214.55 | 14.88B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
514.59 | 172.95B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
205.08 | 58.89B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
94.94 | 45.20B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
235.88 | 30.92B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
80.89 | 16.11B | 3.90B | 392.30M | 288.10M | 1.95 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2025 Earnings Call Transcript - Insider Monkey
West Pharmaceutical Services Earnings Call: Mixed Sentiments and Strategic Shifts - TipRanks
Press Release Distribution & PR Platform - ACCESS Newswire
West Pharmaceutical Services, Inc [WST] Shares Fall Approximately -43.90% Over the Year - knoxdaily.com
Jefferies & Co Adjusts West Pharmaceutical Services Price Target to $245 From $240, Maintains Buy Rating - marketscreener.com
West Pharmaceutical: Q1 Earnings Snapshot - Huron Daily Tribune
West Pharmaceutical Services and Philadelphia Eagles Partner for Earth Day Initiative - MyChesCo
West Pharmaceutical Services Reports Q1 2025 Earnings - TipRanks
West Pharmaceutical Services (WST) Raises 2025 Outlook Following Strong Q1 Results - GuruFocus
West Pharmaceutical Defies Doubters: EPS Jumps, Outlook Raised Despite Tariff Drag - Benzinga
West Pharmaceutical Q1 2025 slides: Sales edge up while EPS declines - Investing.com India
West Pharmaceutical Services, Inc: Weathering Stock Market Storms with 15.33B Market Cap - investchronicle.com
West Pharmaceutical Services expects to take at least a $20M hit from Trump tariffs - The Business Journals
WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit - TradingView
West Pharma falls as it expects lower growth from drug components business - TradingView
Earnings call transcript: West Pharmaceutical Q1 2025 earnings beat forecasts - Investing.com
West Pharmaceutical CFO Bernard Birkett to Retire - marketscreener.com
West Pharmaceutical Services beats Q1 estimates, raises guidance By Investing.com - Investing.com Canada
West Pharmaceutical Announces Leadership Changes Amid Succession Planning - TipRanks
West Pharmaceutical Services beats Q1 estimates, raises guidance - Investing.com Australia
West Pharmaceutical Services Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits - Quantisnow
West Pharmaceutical Services, Inc. Announces Management Changes - marketscreener.com
West Pharmaceutical Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow
West Pharma raises profit forecast as dollar weakens amid Trump's tariff policies - Reuters
West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates - Yahoo Finance
West Pharmaceutical Services Inc. Q1 Profit Decreases, But Beats Estimates - Nasdaq
West Pharmaceutical Services earnings beat by $0.22, revenue topped estimates - Investing.com Australia
(WST) West Pharmaceutical Services Expects Full Year 2025 Net Sales Range $2.95B$2.98B, vs. FactSet Est of $2.90B - marketscreener.com
(WST) West Pharmaceutical Services Expects Full Year 2025 Adjusted EPS Range $6.15$6.35, vs. FactSet Est of $6.11 - marketscreener.com
West Pharmaceutical Reshapes Leadership: CFO Steps Down as New Segment Chief Brings DuPont Experience - Stock Titan
West Pharmaceutical Services (NYSE:WST) Exceeds Q1 Expectations, Stock Soars - Yahoo Finance
Earnings Flash (WST) West Pharmaceutical Services Reports Q1 Adjusted EPS $1.45, vs. FactSet Est of $1.23 - marketscreener.com
West Pharmaceutical Boosts 2025 Outlook Despite Q1 Headwinds: Key Metrics and Strategic Shifts Revealed - Stock Titan
West Pharmaceutical Services (NYSE:WST) Upgraded at Stephens - Defense World
West Pharmaceutical Q1 2025 Earnings Preview - MSN
Insights Ahead: West Pharmaceutical Servs's Quarterly Earnings - Benzinga
West Pharmaceutical Services Earnings: What To Look For From WST - Yahoo Finance
Ready to Jump After Recent Trade: West Pharmaceutical Services, Inc (WST) - Sete News
West Pharmaceutical Services Inc (WST) Trading 4.01% Higher on Apr 22 - GuruFocus
Examining the Potential Price Growth of West Pharmaceutical Services, Inc (WST) - knoxdaily.com
Milestone Pharmaceuticals Inc [MIST] Investment Guide: What You Need to Know - knoxdaily.com
Will Segmental Performance Drive West Pharmaceutical's Q1 Earnings? - Nasdaq
West Pharmaceutical Services, Inc. (WST): One of the Low Profile Dividend Champions to Buy - Insider Monkey
Earnings Preview: West Pharmaceutical Services (WST) Q1 Earnings Expected to Decline - Yahoo Finance
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
West Pharmaceutical Services (WST) Expected to Announce Earnings on Thursday - Defense World
West to Host Second-Quarter 2024 Conference Call - Quantisnow
Agree To Purchase West Pharmaceutical Services At $180, Earn 11.2% Annualized Using Options - Nasdaq
Fill Finish Manufacturing Market to Witness Upsurge in Growth - openPR.com
West Pharmaceutical price target lowered to $280 from $285 at BofA - Yahoo Finance
UGI Corporation to Announce Q2 2025 Results with Live Webcast - MyChesCo
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.62%
자본화:
|
볼륨(24시간):